Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Other financing activities (2024 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Other financing activities for 2 consecutive years, with $11.2 million as the latest value for Q4 2025.

  • Quarterly Other financing activities rose 46.72% to $11.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.9 million through Dec 2025, down 30.67% year-over-year, with the annual reading at $11.9 million for FY2025, 30.67% down from the prior year.
  • Other financing activities for Q4 2025 was $11.2 million at Nuvation Bio, up from $166000.0 in the prior quarter.
  • The five-year high for Other financing activities was $11.2 million in Q4 2025, with the low at $166000.0 in Q2 2025.